Patents by Inventor Dae Bang Seo

Dae Bang Seo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11096921
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 24, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20210196776
    Abstract: Disclosed is a composition for preventing or inhibiting influenza virus infection, containing ginseng berry polysaccharides as active ingredients, and the ginseng berry polysaccharides exhibit an inhibitory effect on influenza virus activity or infection due to specific ingredients and structures and, specifically, have an excellent inhibitory effect on neuraminidase activity.
    Type: Application
    Filed: April 26, 2019
    Publication date: July 1, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Donghyun CHO, Suhwan KIM, Juewon KIM, Chan Woong PARK, Dae Bang SEO
  • Publication number: 20210128660
    Abstract: The specification relates to a composition for enhancing immunity, comprising a ginseng berry polysaccharide as an active ingredient. The composition can increase the expression of cytokines such as IL-6, IL-12, and TNF-? by using ingredients derived from natural products. In addition, the composition can exhibit excellent immunity enhancement effects because of the unique components and structure of a ginseng berry polysaccharide.
    Type: Application
    Filed: January 26, 2018
    Publication date: May 6, 2021
    Inventors: Suhwan KIM, Juewon KIM, Chan-woong PARK, Dae Bang SEO, Donghyun CHO, Kwang Soon SHIN, Dae Young LEE
  • Patent number: 10959981
    Abstract: The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: March 30, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Hyun Woo Jeong, Ji Hae Lee, Dae Jin Min, Dae Bang Seo, Sang Jun Lee
  • Publication number: 20200100527
    Abstract: The present invention relates to a liquid food composition comprising a Sophora japonica and a broad-leaf bamboo extract, and more particularly, to a liquid food composition including a Sophora japonica extract, a broad-leaf bamboo extract, and xanthan gum. The liquid food composition includes a high content of the Sophora japonica extract while simultaneously ensuring the liquid properties, and thus can be used widely in the field of foods because the liquid food composition is applicable to liquid formulations.
    Type: Application
    Filed: August 22, 2019
    Publication date: April 2, 2020
    Applicant: Amorepacific Corporation
    Inventors: Dae Bang SEO, Heeyoung JEON, Sun Mi KIM, Donghyun CHO
  • Patent number: 10555983
    Abstract: Provided in the present specification is a composition for brain activation, comprising ginseng fruit extract as an active ingredient. The composition according to the present specification allows an increase in blood flow in the brain and thus has an effect of ameliorating chronic fatigue syndrome. In addition, the composition according to the present specification activates the brain, and as a result, strengthens connectivity strength between the frontal lobe and the occipital lobe and thus has an effect of improving problem-solving accuracy and reducing solving time in the area of cognitive ability. Therefore, the composition according to the present specification can be used as a pharmaceutical composition or a food composition for patients suffering from chronic fatigue syndrome.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: February 11, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Chan Woong Park, Su Hwan Kim, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20190167745
    Abstract: The present invention relates to a composition containing a bean extract extracted by low-concentration, low-grade alcohol or fractions thereof. The composition exhibits excellent effects in improving blood circulation, improving obesity, and preventing diabetes, hyperlipidemia and the like, and exhibits the effects of alleviating or treating the symptoms of diabetes, hyperlipidemia, and the like. The present invention also relates to a method for improving blood circulation and vascular health.
    Type: Application
    Filed: February 4, 2019
    Publication date: June 6, 2019
    Inventors: Hyun J. Shin, Jin Kwan KIM, Chae Wook KIM, Kyung Mi JOO, Yeon Su JEONG, Kyung Min LIM, Dae-Bang SEO, Yung Hyup JOO, Sang Jun LEE, Young-Ho PARK
  • Patent number: 10279076
    Abstract: The present invention relates to a parenteral composition for maintaining the efficacy of a filler for a long time, containing a collagen hydrolysate as an active ingredient. The composition, according to the present invention, can maintain the efficacy of a hyaluronic acid filler for a longer time, thereby enabling the effect thereof to be maintained irrespective of a smaller frequency of filler operations, and thus there is an advantage of also reducing skin irritation. In addition, there is an advantage of enabling an immediate effect since an administration method is simple as a parenteral administration and enables direct penetration into the skin.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: May 7, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Jin Kyu Choi, Byung Gyu Kim, Dae Bang Seo
  • Patent number: 10183048
    Abstract: Disclosed is a composition for promoting the activity of peroxisome proliferator-activated receptor-? (PPAR-?), which contains Artemisia vulgaris extracts or Artemisia capillaris extracts as active ingredients. The composition is effective in strengthening muscles, improving endurance and memory, and preventing and alleviating the symptoms of dementia or Parkinson's disease.
    Type: Grant
    Filed: November 25, 2010
    Date of Patent: January 22, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Si Young Cho, Pil Joon Park, Ji Hae Lee, Dae Bang Seo, Sang Jun Lee
  • Patent number: 10172900
    Abstract: The present invention relates to a ginseng mixed composition with improved bioavailability of saponin. Further, the present invention relates to a method for improving saponin bioavailability of a subject comprising: administering to the subject an effective amount of at least one extract selected from a Schizandra chinensis extract and a Liriope platyphylla extract that improves saponin bioavailability in the subject.
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: January 8, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hee Young Jeon, Ji Hae Lee, Kyung Mi Joo, Chan Woong Park, Kyung Min Lim, Dae Bang Seo, Sang Jun Lee
  • Patent number: 10111856
    Abstract: The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.
    Type: Grant
    Filed: May 7, 2014
    Date of Patent: October 30, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Hyun Woo Jeong, Ji Hae Lee, Dae Jin Min, Dae Bang Seo, Sang Jun Lee
  • Publication number: 20180271830
    Abstract: The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.
    Type: Application
    Filed: May 25, 2018
    Publication date: September 27, 2018
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung SHIN, Hyun Woo JEONG, Ji Hae LEE, Dae Jin MIN, Dae Bang SEO, Sang Jun LEE
  • Patent number: 10080375
    Abstract: Disclosed are a fermented tea obtained by inoculating tea with a microbial strain derived from fermented soybean sauce, and a method for producing the fermented tea. The fermented tea has superior taste and aroma, exhibits an outstanding improving effect on blood circulation and alleviating effect on cold hands and feet, and can be used various ways in the field of health foods or medical products.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: September 25, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Bum Jin Lee, Ji Eun Lee, Yu Jin Oh, Jin Oh Chung, Dae Bang Seo, Sang Jun Lee
  • Patent number: 10022351
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: July 17, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9999611
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: June 19, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9913823
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: March 13, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9839660
    Abstract: The present invention provides a composition comprising Astragali Radix extract as an active ingredient. The composition can increase body energy consumption and muscle metabolism. The present invention also relates to pharmaceutical and food compositions which include a composition comprising the Astragali Radix extract. The pharmaceutical and food compositions also increase body energy consumption and muscle metabolism.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: December 12, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Pil Joon Park, Si Young Cho, Dae Bang Seo, Sang Jun Lee
  • Patent number: 9795583
    Abstract: The present invention relates to a composition for preventing or treating heart disease, and more particularly, to a composition for preventing or treating heart disease, comprising (+)-syringaresinol. Specifically, (+)-syringaresinol as an active ingredient may exhibit excellent effect of preventing or improving heart disease by promoting SIRT1 expression and suppressing death of cardiomyocytes induced by reactive oxygen species. Accordingly, the composition according to the present disclosure may be used to prevent, improve or treat heart diseases including cardiovascular diseases.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: October 24, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Si Young Cho, Dae Bang Seo, Chan Woong Park, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9655878
    Abstract: The present invention relates to a composition which comprises as an active ingredient coumestrol or a bean extract containing coumestrol, whereby adipocyte differentiation is inhibited, the immune system of the body is improved, toxic substances are purged, and neurodegenerative disorders are prevented or improved.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: May 23, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hee Y. Jeon, Hyun Jung Shin, Dae Bang Seo, Hyeon Ju Yeo, Sang Jun Lee
  • Publication number: 20170136146
    Abstract: The present invention relates to a parenteral composition for maintaining the efficacy of a filler for a long time, containing a collagen hydrolysate as an active ingredient. The composition, according to the present invention, can maintain the efficacy of a hyaluronic acid filler for a longer time, thereby enabling the effect thereof to be maintained irrespective of a smaller frequency of filler operations, and thus there is an advantage of also reducing skin irritation. In addition, there is an advantage of enabling an immediate effect since an administration method is simple as a parenteral administration and enables direct penetration into the skin.
    Type: Application
    Filed: March 10, 2015
    Publication date: May 18, 2017
    Inventors: Hyun Jung SHIN, Jin Kyu CHOI, Byung Gyu KIM, Dae Bang SEO